Putting the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization Into Practice: A Case Series.

Authors :: Bittl JA
Bangalore S
DiMaio JM
Grant MC
Lawton JS
Tamis Holland JE
Source :: JACC. Case reports [JACC Case Rep] 2021 Dec 09; Vol. 4 (1), pp. 31-35. Date of Electronic Publication: 2021 Dec 09 (Print Publication: 2022).
Publication Year :: 2021
Abstract: This case series shows how the 2021 ACC/AHA/SCAI guideline for coronary artery revascularization can be used to decide between revascularization or optimal medical therapy to reduce mortality or cardiovascular events in selected subsets of patients with stable ischemic heart disease and complex coronary disease with or without left ventricular dysfunction. ( Level of Difficulty: Advanced. ).<br />Competing Interests: Dr Bangalore is a consultant for Abbott, Amgen, Biotronik, Meril, Pfizer, Reata, and Sahajanand Medical Technologies. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.<br /> (© 2022 The Authors.)

Full Text Access

Tools